Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PULSTA Transcatheter Pulmonary Valve (TPV) Pre-Approval Study

NCT03983512 is registered in ClinicalTrials.gov with Taewoong Medical Co., Ltd. as lead sponsor.

NCT NCT03983512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03983512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PULSTA Transcatheter Pulmonary Valve (TPV) Pre-Approval Study
Lead sponsor
Taewoong Medical Co., Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 7, 2019
Completion date
December 31, 2026
Enrollment
58 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

heart diseases, pulmonary valve regurgitation, pulmonary valve stenosis, tetralogy of fallot